These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 18221080)

  • 1. Novel drugs and the response to hypoxia: HIF stabilizers and prolyl hydroxylase.
    Nangaku M; Kojima I; Tanaka T; Ohse T; Kato H; Fujita T
    Recent Pat Cardiovasc Drug Discov; 2006 Jun; 1(2):129-39. PubMed ID: 18221080
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HIF-prolyl hydroxylases and cardiovascular diseases.
    Sen Banerjee S; Thirunavukkarasu M; Tipu Rishi M; Sanchez JA; Maulik N; Maulik G
    Toxicol Mech Methods; 2012 Jun; 22(5):347-58. PubMed ID: 22424133
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypoxia-inducible factor prolyl-hydroxylase: purification and assays of PHD2.
    Hewitson KS; Schofield CJ; Ratcliffe PJ
    Methods Enzymol; 2007; 435():25-42. PubMed ID: 17998047
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic analysis of the role of the asparaginyl hydroxylase factor inhibiting hypoxia-inducible factor (FIH) in regulating hypoxia-inducible factor (HIF) transcriptional target genes [corrected].
    Stolze IP; Tian YM; Appelhoff RJ; Turley H; Wykoff CC; Gleadle JM; Ratcliffe PJ
    J Biol Chem; 2004 Oct; 279(41):42719-25. PubMed ID: 15302861
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypoxia-inducible factor-1 (HIF-1) promotes its degradation by induction of HIF-alpha-prolyl-4-hydroxylases.
    Marxsen JH; Stengel P; Doege K; Heikkinen P; Jokilehto T; Wagner T; Jelkmann W; Jaakkola P; Metzen E
    Biochem J; 2004 Aug; 381(Pt 3):761-7. PubMed ID: 15104534
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of prolyl hydroxylase inhibitors on adipogenesis and hypoxia inducible factor 1 alpha levels under normoxic conditions.
    Floyd ZE; Kilroy G; Wu X; Gimble JM
    J Cell Biochem; 2007 Aug; 101(6):1545-57. PubMed ID: 17370314
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypoxia and hypoxia-inducible factor in renal disease.
    Nangaku M; Inagi R; Miyata T; Fujita T
    Nephron Exp Nephrol; 2008; 110(1):e1-7. PubMed ID: 18667839
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hydroxylation of hypoxia-inducible transcription factors and chemical compounds targeting the HIF-alpha hydroxylases.
    Bruegge K; Jelkmann W; Metzen E
    Curr Med Chem; 2007; 14(17):1853-62. PubMed ID: 17627521
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug discovery for overcoming chronic kidney disease (CKD): prolyl-hydroxylase inhibitors to activate hypoxia-inducible factor (HIF) as a novel therapeutic approach in CKD.
    Tanaka T; Nangaku M
    J Pharmacol Sci; 2009 Jan; 109(1):24-31. PubMed ID: 19151537
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tuning the Transcriptional Response to Hypoxia by Inhibiting Hypoxia-inducible Factor (HIF) Prolyl and Asparaginyl Hydroxylases.
    Chan MC; Ilott NE; Schödel J; Sims D; Tumber A; Lippl K; Mole DR; Pugh CW; Ratcliffe PJ; Ponting CP; Schofield CJ
    J Biol Chem; 2016 Sep; 291(39):20661-73. PubMed ID: 27502280
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The peptidyl prolyl cis/trans isomerase FKBP38 determines hypoxia-inducible transcription factor prolyl-4-hydroxylase PHD2 protein stability.
    Barth S; Nesper J; Hasgall PA; Wirthner R; Nytko KJ; Edlich F; Katschinski DM; Stiehl DP; Wenger RH; Camenisch G
    Mol Cell Biol; 2007 May; 27(10):3758-68. PubMed ID: 17353276
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The oxygen sensor factor-inhibiting hypoxia-inducible factor-1 controls expression of distinct genes through the bifunctional transcriptional character of hypoxia-inducible factor-1alpha.
    Dayan F; Roux D; Brahimi-Horn MC; Pouyssegur J; Mazure NM
    Cancer Res; 2006 Apr; 66(7):3688-98. PubMed ID: 16585195
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression and DNA methylation levels of prolyl hydroxylases PHD1, PHD2, PHD3 and asparaginyl hydroxylase FIH in colorectal cancer.
    Rawluszko AA; Bujnicka KE; Horbacka K; Krokowicz P; Jagodziński PP
    BMC Cancer; 2013 Nov; 13():526. PubMed ID: 24195777
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Investigating the dependence of the hypoxia-inducible factor hydroxylases (factor inhibiting HIF and prolyl hydroxylase domain 2) on ascorbate and other reducing agents.
    Flashman E; Davies SL; Yeoh KK; Schofield CJ
    Biochem J; 2010 Mar; 427(1):135-42. PubMed ID: 20055761
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of a prolyl hydroxylase domain (PHD) by substrate analog peptides.
    Kwon HS; Choi YK; Kim JW; Park YK; Yang EG; Ahn DR
    Bioorg Med Chem Lett; 2011 Jul; 21(14):4325-8. PubMed ID: 21665470
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulation of the Hypoxic Response.
    Pugh CW
    Adv Exp Med Biol; 2016; 903():259-71. PubMed ID: 27343102
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preconditional activation of hypoxia-inducible factors ameliorates ischemic acute renal failure.
    Bernhardt WM; Câmpean V; Kany S; Jürgensen JS; Weidemann A; Warnecke C; Arend M; Klaus S; Günzler V; Amann K; Willam C; Wiesener MS; Eckardt KU
    J Am Soc Nephrol; 2006 Jul; 17(7):1970-8. PubMed ID: 16762988
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HIF prolyl-hydroxylase 2 is the key oxygen sensor setting low steady-state levels of HIF-1alpha in normoxia.
    Berra E; Benizri E; Ginouvès A; Volmat V; Roux D; Pouysségur J
    EMBO J; 2003 Aug; 22(16):4082-90. PubMed ID: 12912907
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prolyl hydroxylase inhibitor treatment confers whole-animal hypoxia tolerance.
    Kasiganesan H; Sridharan V; Wright G
    Acta Physiol (Oxf); 2007 Jun; 190(2):163-9. PubMed ID: 17394573
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prolyl hydroxylases 2 and 3 act in gliomas as protective negative feedback regulators of hypoxia-inducible factors.
    Henze AT; Riedel J; Diem T; Wenner J; Flamme I; Pouyseggur J; Plate KH; Acker T
    Cancer Res; 2010 Jan; 70(1):357-66. PubMed ID: 20028863
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.